DOCUMENT

COVID-19 Normal “Finding a therapy that enhances remyelination during MS has become the newest holy grail in MS research as this type of therapy would provide benefit to all people with MS, both relapsing-remitting and progressive,” - Professor La Flamme Headlines 9